25243-7 |
Ceftizoxime |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Ceftizoxime [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25243-7 |
|
|
|
|
Both |
|
|
|
0 |
Ceftizoxime Spec-mCnc |
|
|
|
Y |
|
Cefizox; Ceftrix; DRUG/TOXICOLOGY; Drugs; Eposelin; Eposerin; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25244-5 |
cefTRIAXone |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
cefTRIAXone [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25244-5 |
|
|
|
|
Both |
|
|
|
0 |
cefTRIAXone Spec-mCnc |
|
|
|
Y |
|
c9; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Rocephin; ROCJ; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25245-2 |
Cefuroxime.parenteral |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Cefuroxime Parenteral [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25245-2 |
|
|
|
|
Both |
|
|
|
0 |
Cefuroxime Parenter Spec-mCnc |
|
|
|
Y |
|
c308; C33; Ceftin; Cefuroxime Axetil; Cefuroxime Parenter; Cefuroxime Sodium; Curoxim; DRUG/TOXICOLOGY; Drugs; Kefurox; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Ultroxim; Unspecified; Zinacef |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25246-0 |
Cephalothin |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Cephalothin [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25246-0 |
|
|
|
|
Both |
|
|
|
0 |
Cephalothin Spec-mCnc |
|
|
|
Y |
|
Cefalotin; Cephalotin; Ceporacin; Cepovenin; DRUG/TOXICOLOGY; Drugs; Keflin; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25247-8 |
Chloramphenicol |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Chloramphenicol [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25247-8 |
|
|
|
|
Both |
|
|
|
0 |
Chloramphen Spec-mCnc |
|
|
|
Y |
|
Amphicol; Biophenicol; c225; Chloramphen; Chloromycetin; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Mychel; Other; Paraxin; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25248-6 |
Ciprofloxacin |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Ciprofloxacin [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25248-6 |
|
|
|
|
Both |
|
|
|
0 |
Ciprofloxacin Spec-mCnc |
|
|
|
Y |
|
c250; c307; C81; Ciloxan; Cipro; Ciprofloxacn; Ciprofloxin; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25249-4 |
Clindamycin |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Clindamycin [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25249-4 |
|
|
|
|
Both |
|
|
|
0 |
Clindamycin Spec-mCnc |
|
|
|
Y |
|
c306; Cleocin; CLIJ; Dalacin; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Sobelin; Spec; To be specified in another part of the message; Topical; Unspecified |
2.73 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
2525-4 |
Lactate |
SCnc |
Synv fld |
Pt |
Qn |
|
|
ACTIVE |
Lactate [Moles/volume] in Synovial fluid |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
2525-4 |
|
|
|
|
Both |
|
|
|
0 |
Lactate Snv-sCnc |
|
|
|
Y |
|
2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Chemistry; Joint aspirate; Joint fld; Joint flu; Joint fluid; Lact; Lactic acid; Level; L-lactate; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Substance Concentration; Syn; Syn fl; Synov; Synovial fluid |
2.34 |
1 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
25250-2 |
Cloxacillin |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Cloxacillin [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25250-2 |
|
|
|
|
Both |
|
|
|
0 |
Cloxacillin Spec-mCnc |
|
|
|
Y |
|
Alclox; Ampiclox; Amplium; APO-CLOXI; Austrastaph; Clocillin; Cloxin; DRUG/TOXICOLOGY; Drugs; Ekvacillin; Level; Mass concentration; Misc; Miscellaneous; Novo-cloxi; Nu-cloxi; Orbenin; Other; Penstapho n; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Tegopen; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25251-0 |
cycloSERINE |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
cycloSERINE [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25251-0 |
|
|
|
|
Both |
|
|
|
0 |
cycloSERINE Spec-mCnc |
|
|
|
Y |
|
Closina; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Oxamycin; Point in time; QNT; Quan; Quant; Quantitative; Random; Seromycine; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25252-8 |
Dicloxacillin |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Dicloxacillin [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25252-8 |
|
|
|
|
Both |
|
|
|
0 |
Dicloxacillin Spec-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Dynapen; Level; Mass concentration; Misc; Miscellaneous; Other; Pathocil; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Veracillin; Veracilline |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25253-6 |
Clarithromycin |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Clarithromycin [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25253-6 |
|
|
|
|
Both |
|
|
|
0 |
Clarithro Spec-mCnc |
|
|
|
Y |
|
Biaxin; Claripen; DRUG/TOXICOLOGY; Drugs; Klacid; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25254-4 |
Ticarcillin |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Ticarcillin [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25254-4 |
|
|
|
|
Both |
|
|
|
0 |
Ticarcillin Spec-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Ticar; Timentin; TIMJ; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25255-1 |
Fluconazole |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Fluconazole [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25255-1 |
|
|
|
|
Both |
|
|
|
0 |
Fluconazole Spec-mCnc |
|
|
|
Y |
|
Diflucan; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25256-9 |
Ganciclovir |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Ganciclovir [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25256-9 |
|
|
|
|
Both |
|
|
|
0 |
Ganciclovir Spec-mCnc |
|
|
|
Y |
|
Cytovene; DRUG/TOXICOLOGY; Drugs; GCV; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified; Valcyte; Valganciclovir |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25257-7 |
Imipenem |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Imipenem [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25257-7 |
|
|
|
|
Both |
|
|
|
0 |
Imipenem Spec-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Imipeneum; Imp; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; Primaxin; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25258-5 |
Itraconazole |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Itraconazole [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25258-5 |
|
|
|
|
Both |
|
|
|
0 |
Itraconaz Spec-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Sporanax; Sporanox; To be specified in another part of the message; Unspecified |
2.73 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25259-3 |
Ketoconazole |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Ketoconazole [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25259-3 |
|
|
|
|
Both |
|
|
|
0 |
Ketoconazole Spec-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Nizoral; NZ; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
2526-2 |
Lactate |
MRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Lactate [Mass/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
mg/24 H |
|
|
|
|
|
|
CHEM |
|
2526-2 |
|
|
|
|
Both |
|
|
|
0 |
Lactate 24h Ur-mRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Chemistry; Lact; Lactic acid; L-lactate; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.42 |
1 |
|
|
|
|
|
|
|
mg/(24.h) |
|
|
|
0 |
25261-9 |
Nalidixate |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Nalidixate [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25261-9 |
|
|
|
|
Both |
|
|
|
0 |
Nalidixate Spec-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Nalidix; Nalidixic acid; NEG; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25262-7 |
Neomycin |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Neomycin [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25262-7 |
|
|
|
|
Both |
|
|
|
0 |
Neomycin Spec-mCnc |
|
|
|
Y |
|
Aminoglycosides; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Neosporin; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25263-5 |
Netilmicin |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Netilmicin [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25263-5 |
|
|
|
|
Both |
|
|
|
0 |
Netilmicin Spec-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Netilimicin; Netromycin; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25264-3 |
Ofloxacin |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Ofloxacin [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25264-3 |
|
|
|
|
Both |
|
|
|
0 |
Ofloxacin Spec-mCnc |
|
|
|
Y |
|
c409; DRUG/TOXICOLOGY; Drugs; Floxin; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25265-0 |
Oxacillin |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Oxacillin [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25265-0 |
|
|
|
|
Both |
|
|
|
0 |
Oxacillin Spec-mCnc |
|
|
|
Y |
|
Bactocill; c116; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Misc; Miscellaneous; Other; Point in time; Prostaphlin; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
25266-8 |
Oxytetracycline |
MCnc |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Oxytetracycline [Mass/volume] in Specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
25266-8 |
|
|
|
|
Both |
|
|
|
0 |
Oxytetracycline Spec-mCnc |
|
|
|
Y |
|
Berkmycen; Clinimycin; DRUG/TOXICOLOGY; Drugs; Glomicin; Hydroxytetracycline; Imperacon; Level; Mass concentration; Misc; Miscellaneous; Other; Oxymicin; Oxytetramix; Point in time; QNT; Quan; Quant; Quantitative; Random; Riomitsin; Spec; Terramicina; Terramycin; Terramycine; Terravenos; To be specified in another part of the message; Unspecified |
2.7 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |